NFE2L2 and Huntington disease: The triazole-containing NRF2 inducer 5-nitro-2-{[5-(phenoxymethyl)-4-phenyl-4H-1,2,4-triazol-3-yl]thio}pyridine (MIND4-17) increased NQO1 and GCLM expression in neural stem cells differentiated from HD patient-derived induced pluripotent stem cells [131].